Related references
Note: Only part of the references are listed.Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas
Catherine Godfraind et al.
ACTA NEUROPATHOLOGICA (2012)
Correlation of p53 and KI-67 expression with grade and subtype of ependymoma
Lakshmi P. Manasa et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2012)
Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients
Joon Seon Song et al.
PATHOLOGY INTERNATIONAL (2012)
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Till Milde et al.
ACTA NEUROPATHOLOGICA (2011)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt et al.
CANCER CELL (2011)
(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells
Vijayalakshmi Nandakumar et al.
CARCINOGENESIS (2011)
Primary anaplastic ganglioglioma with a small-cell glioblastoma component
J. Schittenhelm et al.
CLINICAL NEUROPATHOLOGY (2011)
Histone Acetylation Patterns of Typical and Atypical Pituitary Adenomas Indicate Epigenetic Shift of these Tumours
A. Ebrahimi et al.
JOURNAL OF NEUROENDOCRINOLOGY (2011)
Biological significance of protein modifications in aging and calorie restriction
Akihiro Nakamura et al.
AGING, CANCER, AND AGE-RELATED DISEASES: COMMON MECHANISM? (2010)
Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells
K. Almstrup et al.
BRITISH JOURNAL OF CANCER (2010)
Association of Global Levels of Histone Modifications with Recurrence-Free Survival in Stage IIB and III Esophageal Squamous Cell Carcinomas
I Hoseok et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Global Histone Modification Patterns as Prognostic Markers to Classify Glioma Patients
Bo-lin Liu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Molecular Staging of Intracranial Ependymoma in Children and Adults
Andrey Korshunov et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Robert A. Johnson et al.
NATURE (2010)
Genome-wide profiling of histone H3 lysine 9 acetylation and dimethylation in Arabidopsis reveals correlation between multiple histone marks and gene expression
Junli Zhou et al.
PLANT MOLECULAR BIOLOGY (2010)
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
David B. Seligson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Concepts of epigenetics in prostate cancer development
C. S. Cooper et al.
BRITISH JOURNAL OF CANCER (2009)
Expression Profiling of Ependymomas Unravels Localization and Tumor Grade-Specific Tumorigenesis
Thomas Palm et al.
CANCER (2009)
The genetic and epigenetic basis of ependymoma
Stephen C. Mack et al.
CHILDS NERVOUS SYSTEM (2009)
Histone acetylation Where to go and how to get there
Vicki E. MacDonald et al.
EPIGENETICS (2009)
Diagnostic value of WT1 in neuroepithelial tumours
J. Schittenhelm et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
Molecular Epigenetics and Genetics in Neuro-Oncology
Raman P. Nagarajan et al.
NEUROTHERAPEUTICS (2009)
Immunohistochemical Prognostic Markers in Intracranial Ependymomas: Systematic Review and Meta-Analysis
Klara Kuncova et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma
Young Soo Park et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue:: class II and IV are hypoexpressed in glioblastomas
Agda Kb Lucio-Eterovic et al.
BMC CANCER (2008)
Combinatorial patterns of histone acetylations and methylations in the human genome
Zhibin Wang et al.
NATURE GENETICS (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Global histone modifications predict prognosis of resected non-small-cell lung cancer
Fabrice Barlesi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Histone modifications as markers of cancer prognosis: a cellular view
S. K. Kurdistani
BRITISH JOURNAL OF CANCER (2007)
Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing
Jiejun Wu et al.
BMC GENOMICS (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics
Piergiorgio Modena et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma
F Mendrzyk et al.
CLINICAL CANCER RESEARCH (2006)
Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo
C Graham et al.
CLINICAL CANCER RESEARCH (2006)
Radial glia cells are candidate stem cells of ependymoma
MD Taylor et al.
CANCER CELL (2005)
DNA methylation and histone modifications: teaming up to silence genes
F Fuks
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Global histone modification patterns predict risk of prostate cancer recurrence
DB Seligson et al.
NATURE (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
The histone deacetylase 9 gene encodes multiple protein isoforms
K Petrie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups
S Dyer et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Immunohistochemical markers for prognosis of ependymal neoplasms
A Korshunov et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Genetic abnormalities detected in genomic hybridisation epenclymomas by comparative
M Carter et al.
BRITISH JOURNAL OF CANCER (2002)
Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups
Y Hirose et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5
XB Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
